A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
GlaxoSmithKline
GlaxoSmithKline
Nuvation Bio Inc.
Pfizer
OHSU Knight Cancer Institute
AstraZeneca
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center